Cyclin-Dependent Kinase Inhibitors as Anticancer Drugs

E-ISSN： 1873-5592|11|3|291-302

ISSN： 1389-4501

Source： Current Drug Targets, Vol.11, Iss.3, 2010-03, pp. : 291-302

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cyclin-dependent kinase inhibitors: novel anticancer agents

By Mani S. Wang C. Wu K. Francis R. Pestell R.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 8, 2000-08 ,pp. : 1849-1870

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological Cyclin-Dependent Kinase Inhibitors (PCIs) as Potential Antiviral Drugs

Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol. 5, Iss. 4, 2006-10 ,pp. : 345-355

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of Cyclin-Dependent Kinases as Anti-Cancer Therapeutics

Current Medicinal Chemistry, Vol. 7, Iss. 12, 2000-12 ,pp. : 1213-1245

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclin-dependent kinase inhibitors closer to market launch?

By Galons Hervé

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 8, 2013-08 ,pp. : 945-963

Informa Healthcare

Access to resources Recommend Favorite

The Cyclin-Dependent Kinase Inhibitor p21CDKN1A as a Target of Anti-Cancer Drugs

Current Cancer Drug Targets, Vol. 12, Iss. 2, 2012-02 ,pp. : 85-96

Bentham Science Publishers

Access to resources Recommend Favorite